Department of Pharmacology and Toxicology
Dr. Anuradha S. Majumdar
Associate Professor & Head, Department of Pharmacology
Bombay College of Pharmacy, University of Mumbai
Former Dean, Faculty of Science & Technology, University of Mumbai
Editor, Pharma Times (2024β2026) | Chairperson, Institutional Animal Ethics Committee (IAEC)

27+ YearsExperience
60+Publications
6 PatentsGranted
βΉ3+ CroreResearch Funding
Professional Overview
- Distinguished academician and researcher with 27+ years in pharmacological sciences
- Former Dean, Faculty of Science & Technology, University of Mumbai
- Guided 100+ M.Pharm and 8 Ph.D. scholars
- Strong focus on translational and interdisciplinary pharmacology
Research Areas
- Mitochondrial & Energy Metabolism
- Environmental Toxicology
- Drug Delivery Systems
- Neuropharmacology & Herbal Research
- Herbal & Integrative Pharmacology
Academic & Administrative Leadership
- Former Dean, Univ. of Mumbai
- NAAC A++ Contributor (CGPA 3.65)
- Led 823+ colleges & 54 PG departments
- Member: Senate, Academic Council & Management Council
Research Output
- 60+ peer-reviewed publications
- 1500+ citations (Google Scholar)
- 13 Government-funded projects
- Multiple industry collaborations (e.g., Cipla)
Grants & Collaborations
- βΉ3+ Crore research funding
- BRNS, DBT, DST, UGC funded projects
- International collaboration: University of Tasmania
- Industry partnerships and translational projects
Educational Qualifications:
| Sr. No. | Degree | University | Year of Passing |
|---|---|---|---|
| 1 | PhD (Tech.) | Mumbai University | 2006 |
| 2 | M. Pharm | Nagpur University | 1996 |
| 3 | B. Pharm | Nagpur University | 1994 |
Recent Publications: (Best Five in last five years)
| Sr. No. | Paper Title(Best Five in last five years) | Jounal Details |
|---|---|---|
| 1 | Nose to brain delivery of flurbiprofen from a solid lipid nanoparticles-based thermosensitive in-situ gel | Ashok Choudhary, Sakshi Mahajan, Anuradha Majumdar, Nose to brain delivery of flurbiprofen from a solid lipid nanoparticles-based thermosensitive in-situ gel. Neuroscience Applied 3 (2024) 104062 |
| 2 | Network Pharmacology Analysis of Chandraprabha Vati: A New Hope for the Treatment of Metabolic Syndrome | Prashant Dongre and Anuradha Majumdar, Network Pharmacology Analysis of Chandraprabha Vati: A New Hope for the Treatment of Metabolic Syndrome. February 2024, Journal of Ayurveda and Integrative Medicine, https://doi.org/10.1016/j.jaim.2024.100902, Impact factor: 2.4 |
| 3 | All-trans-retinoic acid and valproic acid: A combinatorial approach for the treatment of nephrotic syndrome | Current Research in Biotechnology 7 (2024), https://doi.org/10.1016/j.crbiot.2024.100181, Impact factor: |
| 4 | Green tea as SIRT1 and SIRT3 activator in COVID-19 | A molecular docking approach, Indian Journal of Natural Products Page 4 of 9 and Resources, Vol. 14(3), September 2023, pp 409-424, DOI: 10.56042/ijnpr.v14i3.5397, Impact factor: 0.192 |
| 5 | Therapeutic potential of endoplasmic reticulum stress inhibitors in the treatment of diabetic peripheral neuropathy | Metabolic Brain Disease, https;//doi.org/10.1007/s11011-023-01239-x, Impact factor: 3.584 |
| 6 | Crosstalk between Sirtuins and Nrf2 | SIRT1 activators as emerging treatment for diabetic neuropathy, Metabolic Brain Disease, https;//doi.org/10.1007/s11011-022-00956-z, Impact factor: 3.584 |
| 7 | Pyrroloquinoline Quinine | inhibits PCSK9, augments LDLR recycling and enhances the effect of atorvastatin. bioRxiv preprint doi:https://doi.org/10.1101/2022.03.20.485060 |
| 8 | A new prospect for the treatment of nephrotic syndrome based on network pharmacology analysis | Current Research in Physiology (2022), Volume 5, Pages 36-47, DOI 10.1016/j.crphys.2021.12.004, Cite score 1.5. (Impact Score 2.42) |
| 9 | Role of NRF2 and Sirtuin activators in COVID-19, Clinical Immunology 233 (2021) 108879 | https://doi.org/10.1016/j.clim.2021.108879, Impact Factor: 8.6 |
| 10 | Current Therapies in Nephrotic Syndrome: | HDAC Inhibitors, an Emerging Therapy for Kidney Diseases. Current Research in Biotechnology, May 2021, 3(10141), https://doi.org/10.1016/j.crbiot.2021.05.007, Impact factor: 5.6 |
| 11 | Understanding Skin Chronobiology to Unveil and Transform Dermal Chronotherapeutics | Paving the way for the Future. Chronobiology in Medicine, March 2021, 3 (1), DOI: 10.33069/cim.2020.0032 |
| 12 | Melatonin ameliorates neuropathy in diabetic rats by abating mitochondrial dysfunction and metabolic derangements | Endocrine and Metabolic Science 1 (2020) 100067, https://www.sciencedirect.com/science/article/pii/S2666396120300212?via%3Dihub |
| 13 | Supplementation of pyrroloquinoline quinone with atorvastatin augments mitochondrial biogenesis and attenuates low grade inflammation in obese rats | European Journal of Pharmacology, Volume 881, 15 August 2020, 173273, https://doi.org/10.1016/j.ejphar.2020 (Impact Factor: 5.195) |
| 14 | Prevention of acute graft-versus-host-disease by Withaferin a via suppression of AKT/mTOR pathway. | International Immunopharmacology 84 (2020) 106575, https://doi.org/10.1016/j.intimp.2020.106575 (Impact factor: 5.714) |
| 15 | Pyrroloquinoline quinone attenuates obesity associated low grade inflammation | Obesity Medicine 16, 2019, 100134, https://doi.org/10.1016/j.obmed.2019.100134 (Journal impact factor 1.5) |
| 16 | βEnhanced skin permeation of Methotrexate from penetration enhancer containing vesicles: In vitro optimization and in vivo evaluation | 114: 108770, 2019, Biomedicine and Pharmacotherapy, 114, 2019, DOI https://doi.org/10.1016/j.biopha.2019.108770 (Impact factor: 7.5). |
| 17 | Microneedles for transdermal drug delivery | a systematic review, Drug Development and Industrial Pharmacy, DOI: 10.1080/03639045.2018.1539497 (Impact factor 3.727) |
Recent Patents:(ALL)
| Sr. No. | Patent Title | Patent Number |
|---|---|---|
| 1 | A NOVEL PHARMACEUTICAL COMPOSITION OF TOPICAL METHOTREXATE IN CHRONIC INFLAMMATORY CONDITION | 251524 |
| 2 | Matrix type microneedle patches containing keratolytic agents | 342562 |
| 3 | Novel composition of micronutrients for protection against non-ionising radiation | 368640, |
| 4 | A unique neutraceutical composition to combat colonic inflammation | 381778 |
| 5 | Combinatorial and chrono-pharmacology guided multi-target integrated holistic combination treatment for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis | 522398 |
| 6 | A Hyperkeratotic skin penetrating dissolvable microneedle patch and its formulation | 526934 |
Trademark
| Sr.No. | Trademark Name | Conference Dsetails |
|---|---|---|
| 1 | Health HameshaTM | Developed Mobile and Internet App on Health Information for common citizens in English and many Indian native languages. |
| 2 | StriShaTM | Tools including the digital tool such as mobile app to increase awareness on sexual, reproductive, general health, overall wellbeing and the remedial measures. Launched oral contraceptives information app available at play store in June 2023 with feature of pill reminder for improving compliance, Trademark no 5804100 granted 16/06/2024 |
| 3 | CreatinometerTM | Trademark no 5870400, granted 10/03/2024 |
π§ Contact
π Bombay College of Pharmacy, Kalina, Mumbai β 400098
βοΈ anuradha.majumdar@bcp.edu.in
